Key Takeaways
- On a U-100 insulin syringe, 10 units always equals 0.1 mL regardless of what drug is in the vial, because the syringe marks volume, not drug mass.
- Whether 0.1 mL of your semaglutide vial delivers 0.25 mg or 0.5 mg or another dose depends entirely on the vial concentration, which must be read from the label.
- FDA-approved Ozempic uses a prefilled pen, not a vial; the units-to-mL question only applies to compounded or research vials that require manual drawing.
- A tenfold dosing error is physically possible if you assume a concentration that does not match your actual vial.
- Semaglutide has a half-life of roughly 7 days in humans, so a dosing error is not quickly cleared from the body, making calculation accuracy critically important.
How Many ML Is 10 Units of Semaglutide?
On a U-100 insulin syringe, 10 units equals exactly 0.1 mL. That conversion is fixed by the syringe design. What changes is how many milligrams of semaglutide are contained in that 0.1 mL, which depends entirely on the concentration of your specific vial. Confirm vial concentration before every calculation.
Table of Contents
- The exact math: units, mL, and mg explained
- Concentration table: what 10 units actually delivers by vial strength
- What the syringe markings actually measure
- Evidence ledger
- What most pages get wrong about semaglutide units
- How to calculate your correct volume: step-by-step
- How compounded vials compare to FDA-approved pens for dosing accuracy
- How to read a compounded semaglutide label
- Does degradation affect how many mg you actually get?
- Frequently asked questions
- Sources
What Is the Exact Math Connecting Units, ML, and MG?
Three different measurement systems overlap here, and conflating them is the source of nearly every dosing error.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Units on an insulin syringe are a volume measurement. A U-100 syringe is calibrated so that 100 units equals 1 mL. Therefore:
- 10 units = 0.10 mL
- 20 units = 0.20 mL
- 50 units = 0.50 mL
- 100 units = 1.00 mL
This relationship is fixed and does not change with the drug inside.
Milligrams (mg) measure drug mass. To find how many milligrams are in a given volume, multiply volume in mL by concentration in mg per mL:
mg delivered = mL drawn x concentration (mg/mL)
Example: 0.1 mL drawn from a 2.5 mg/mL vial delivers 0.25 mg of semaglutide.
Example: 0.1 mL drawn from a 5 mg/mL vial delivers 0.50 mg of semaglutide.
Same syringe markings, same volume drawn, double the dose. This is why reading the vial label is not optional.
What Does 10 Units (0.1 mL) Actually Deliver at Different Vial Concentrations?
| Vial Concentration | 10 Units (0.1 mL) Delivers | Common Use Case | Notes |
|---|---|---|---|
| 1 mg/mL | 0.10 mg | Low-concentration compounded vials | Larger volume needed for therapeutic doses |
| 2 mg/mL | 0.20 mg | Some compounders | Starting dose range for some protocols |
| 2.5 mg/mL | 0.25 mg | Common compounded standard | Matches Ozempic 0.25 mg starting dose at 10 units |
| 5 mg/mL | 0.50 mg | Higher-concentration compounded vials | 10 units here equals the Ozempic 0.5 mg maintenance dose |
| 10 mg/mL | 1.00 mg | High-concentration research vials | Very small draw volume; magnifies measurement error |
What Do the Markings on a U-100 Insulin Syringe Actually Measure?
A U-100 insulin syringe was designed specifically for U-100 insulin, which contains 100 units of insulin per mL. The engineers marked 100 graduations in 1 mL, so each graduation equals 0.01 mL and, for insulin only, corresponds to 1 insulin unit of biological activity.
When you load a U-100 syringe with semaglutide, the markings still indicate volume correctly. They indicate nothing about semaglutide pharmacological units, because semaglutide has no standardized unit system equivalent to insulin units. The "units" people informally use for semaglutide syringes are simply a volume shorthand: "10 units" means "the 10-unit graduation on this syringe barrel," which equals 0.1 mL.
This is also why the same language would work for any U-100 syringe drawing any drug: the barrel geometry is the same. The drug inside does not change what the marks mean volumetrically.
Evidence Ledger: Claims on This Page and the Evidence Behind Them
| Claim | Best Evidence Type | Direction | Confidence |
|---|---|---|---|
| U-100 syringe: 100 units = 1 mL (fixed geometry) | USP device standards, syringe manufacturer specifications | Established fact | High |
| Semaglutide half-life approximately 7 days in humans | Human PK data from Ozempic FDA label (Novo Nordisk) | Confirmed | High |
| Ozempic starting dose 0.25 mg weekly | FDA-approved prescribing information for semaglutide (Ozempic) | Confirmed | High |
| Compounded vial concentrations vary by compounder | USP 797 compounding documentation, FDA compounding guidance | Confirmed | High |
| Peptide degradation at room temperature reduces active drug content | General peptide stability literature; no semaglutide-specific degradation kinetics cited here | Directionally established | Moderate |
| Dosing errors with compounded GLP-1 agonists have caused adverse events | FDA MedWatch adverse event reports and FDA safety communications (2024) | Documented | High |
| Reconstitution volume affects final concentration | Basic pharmaceutical compounding chemistry, USP standards | Established fact | High |
What Most Pages Get Wrong About Semaglutide Units
Most dosing FAQ pages answer "how many mL is 10 units" with a single number, typically 0.1 mL, and stop there. That answer is only half correct and, depending on your vial, can be dangerously misleading. Here is what gets omitted:
1. They assume a single standard concentration. There is no universal compounded semaglutide concentration. Compounders produce vials at widely different strengths. A page that says "10 units = 0.25 mg" is assuming a 2.5 mg/mL vial. If your vial is 5 mg/mL, that same draw delivers 0.5 mg, double the assumed dose.
2. They conflate insulin units with syringe markings. Insulin units are a measure of biological activity standardized internationally. Semaglutide milligrams are a mass measurement. When a compounded semaglutide protocol says "take 10 units," it is using insulin syringe graduation language as a volume proxy. The two systems are not interchangeable pharmacologically.
3. They do not mention the FDA's documented safety concern. In 2024, the FDA issued communications specifically about dosing errors with compounded GLP-1 receptor agonists, noting that concentration variability and user confusion between units and milligrams contributed to adverse events. Most commodity FAQ pages do not mention this.
4. They ignore the long half-life problem. Semaglutide's half-life is approximately 7 days (per the Ozempic prescribing information). An overdose is not cleared quickly. Nausea, vomiting, hypoglycemia in people on other agents, and cardiovascular effects can persist. The math error has a multi-day consequence.
How Do I Calculate the Correct Volume for My Semaglutide Dose?
Use this formula every single time:
Volume to draw (mL) = Prescribed dose (mg) / Vial concentration (mg/mL)
Then convert mL to syringe units for drawing:
Syringe units = Volume (mL) x 100
| Prescribed Dose | Vial Concentration | Volume to Draw (mL) | Syringe Units (U-100) |
|---|---|---|---|
| 0.25 mg | 2.5 mg/mL | 0.10 mL | 10 units |
| 0.25 mg | 5 mg/mL | 0.05 mL | 5 units |
| 0.5 mg | 2.5 mg/mL | 0.20 mL | 20 units |
| 0.5 mg | 5 mg/mL | 0.10 mL | 10 units |
| 1.0 mg | 5 mg/mL | 0.20 mL | 20 units |
| 1.0 mg | 2.5 mg/mL | 0.40 mL | 40 units |
How Do Compounded Vials Compare to FDA-Approved Semaglutide Pens for Dosing Accuracy?
| Feature | Compounded Vial + Syringe | FDA-Approved Pen (Ozempic/Wegovy) |
|---|---|---|
| Dose accuracy | Depends on user calculation and draw technique; higher error risk | Pen delivers fixed, pre-set doses; lower user error risk |
| Concentration standardization | Varies by compounder; must verify each vial | Fixed by manufacturer; consistent lot to lot |
| Regulatory status | Not FDA-approved; compounded under 503A/503B pharmacy rules | FDA-approved; established safety and efficacy data |
| Purity verification | Requires COA from compounder; not independently verified by FDA | FDA manufacturing standards, batch release testing |
| Cost | Typically lower out of pocket | High list price; varies substantially with insurance |
| Dose flexibility | Any dose possible if calculated correctly | Fixed dose increments per pen dial |
| Storage simplicity | Reconstituted vial requires refrigeration; limited use window | Pre-filled; simpler storage for patients |
Honest verdict: FDA-approved pens have a meaningful advantage in dosing accuracy and purity assurance. Compounded vials offer cost and dose flexibility but place the accuracy burden on the user and prescriber. Neither automatically wins; the right choice depends on access, supervision level, and cost constraints.
How Do You Read a Compounded Semaglutide Vial Label?
A properly labeled compounded semaglutide vial should display all of the following. If any are missing, contact the dispensing pharmacy before drawing a dose.
| Label Element | What to Look For | Red Flag |
|---|---|---|
| Drug name | "Semaglutide" (not just "GLP-1") | Generic or trade name only without INN |
| Concentration | Expressed as mg/mL (e.g., "2.5 mg/mL") | Total mg in vial only without per-mL figure |
| Total volume | mL in vial (e.g., "2 mL") | No volume stated |
| Beyond-use date (BUD) | Date after which vial should not be used | No BUD or BUD more than 90 days from compounding |
| Storage instructions | "Refrigerate 2 to 8 C, protect from light" | No storage instructions |
| Pharmacy name and license | Dispensing pharmacy name, state license number | No pharmacy identification |
| Lot number | Traceable batch identifier | No lot number; cannot request COA |
COA check: A certificate of analysis should confirm identity (HPLC or mass spectrometry), purity (percent semaglutide versus related peptides), and sterility testing. Ask the pharmacy for the COA for your lot. If they cannot provide one, that is a sourcing problem, not a minor administrative gap.
Does Peptide Degradation Mean Your 10 Units Delivers Less Than Expected?
Yes, and this is the problem no one discusses in dosing FAQ pages.
Semaglutide is a 31-amino-acid GLP-1 analogue with a C18 fatty diacid chain that extends its half-life in the body. That structural modification improves in-vivo stability. However, once reconstituted in bacteriostatic water and stored in a vial, the peptide is subject to degradation pathways that include hydrolysis and aggregation over time. These processes are accelerated by heat, light exposure, and repeated freeze-thaw cycles.
The practical consequence is that a vial stored incorrectly, or used past its beyond-use date, may contain less active semaglutide per mL than the label states. Your 0.1 mL draw is still 0.1 mL volumetrically, but the milligrams of active, intact peptide are lower. There are no reliable at-home tests for this degradation. The liquid may look identical to a fresh, potent vial.
This is also why the chemistry behind the storage rule matters: refrigeration slows but does not stop hydrolysis. Light can catalyze oxidation of methionine-containing peptide regions. Keeping the vial in an opaque case in the refrigerator, and discarding it at the compounded beyond-use date rather than guessing at visual appearance, is the operationally correct behavior.
Frequently Asked Questions
How many ml is 10 units of semaglutide?
On a standard U-100 insulin syringe, 10 units equals 0.1 mL. This only holds true if you are drawing from a vial reconstituted to a U-100 concentration (1 mg per 0.1 mL is a common compounding standard, but the exact conversion depends entirely on the concentration of your specific vial).
Why does the concentration of my vial change the math?
Semaglutide vials come in different concentrations depending on the compounder or preparation. A 5 mg per mL vial is not the same as a 2 mg per mL vial. The unit markings on an insulin syringe only correspond to a fixed volume, so the milligram dose you actually draw changes with every different concentration.
Are "units" of semaglutide the same as insulin units?
No. Insulin is standardized to international units, and U-100 means 100 insulin units per mL. Semaglutide is dosed in milligrams, not standardized units. When providers say "10 units" of semaglutide they are informally using the syringe markings as a volume shorthand, not a pharmacologically standardized unit.
What syringe should I use to draw semaglutide?
A 1 mL U-100 insulin syringe is the standard choice for subcutaneous semaglutide injections from a vial. The fine graduation markings allow accurate measurement of small volumes like 0.05 mL to 0.5 mL. Confirm the syringe type with whoever prescribed or dispensed your vial.
How do I calculate the correct volume for my prescribed semaglutide dose?
Divide the prescribed milligram dose by the concentration of your vial in mg per mL. For example, if your dose is 0.5 mg and your vial is 5 mg per mL, you draw 0.1 mL. If your vial is 2 mg per mL, you draw 0.25 mL for the same 0.5 mg dose.
What does 10 units look like on an insulin syringe?
On a standard 1 mL U-100 syringe marked from 0 to 100 units, the 10-unit mark is the first major graduation line, corresponding to exactly 0.1 mL of fluid. The liquid column will be short, roughly one-tenth of the barrel length.
Can I use a different syringe size and still hit 10 units?
You can use a 0.5 mL U-100 syringe, where 10 units is still 0.1 mL. A 0.3 mL syringe also works. Do not use a 1 mL non-insulin syringe with different graduations, as the markings will not align with U-100 unit counting and you risk a dosing error.
What are the most dangerous dosing errors with reconstituted semaglutide?
The most dangerous errors are: assuming concentration without checking the vial label, confusing milligrams with units, using the wrong syringe type, and drawing from a degraded or incorrectly reconstituted vial. A tenfold overdose is physically possible if concentration math is wrong.
How is compounded semaglutide concentration labeled?
Compounded vials should state concentration as mg per mL on the label, for example "5 mg/mL" or "2.5 mg/mL". Some labels also show total milligrams in the vial. Always read both numbers and calculate the volume for your specific dose before drawing.
Does the solvent volume used in reconstitution change the concentration?
Yes. If a compounder or user adds more or less bacteriostatic water than specified, the resulting concentration will differ from the label. Always follow the exact reconstitution instructions provided with your vial and verify the final concentration on the label.
Is 10 units of semaglutide a standard starting dose?
Not universally. FDA-approved Ozempic starts at 0.25 mg weekly. Whether 10 syringe units from a compounded vial equals 0.25 mg depends entirely on the vial concentration. At 2.5 mg per mL, 10 units (0.1 mL) delivers 0.25 mg, which matches the Ozempic starting dose.
How should I store a reconstituted semaglutide vial to maintain concentration accuracy?
Store reconstituted vials refrigerated at 2 to 8 degrees Celsius and protected from light. Peptide degradation at room temperature or above, or after repeated freeze-thaw cycles, can reduce active drug content without any visible change, making your measured volume deliver less active compound than expected.
Sources
- Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration. Available at: FDA.gov. Reviewed 2023.
- U.S. Food and Drug Administration. FDA alerts health care providers and patients about dosing errors with compounded GLP-1 medications. FDA Safety Communication, 2024.
- U.S. Pharmacopeial Convention. USP General Chapter 797: Pharmaceutical Compounding, Sterile Preparations. USP-NF.
- U.S. Food and Drug Administration. Human drug compounding: 503A and 503B pharmacy guidance. FDA.gov.
- Lau J, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380.
- Marbury TC, et al. Pharmacokinetics of semaglutide: exposure and variability in subjects with type 2 diabetes. Diabetes Therapy. 2017.
- U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA.gov. 2021, updated 2023.